Investor Relations

At the intersection of regenerative medicine and hospitality, BioLife Science is building a scalable platform for personalized health and longevity.

Contact Investor Relations

Investor Thesis

The global regenerative medicine category is expanding rapidly, supported by advances in stem cells, peptides, AI‑driven personalization, and consumer demand for proactive longevity care. BioLife Science is positioned to disrupt legacy wellness models with a high‑touch, data‑driven, membership experience that scales.

  • Market Tailwinds: rising adoption of precision health, hormone & metabolic optimization, and recovery therapies across demographics 18–80+.
  • Disruption: science‑first protocols delivered in elevated, spa‑inspired centers — redefining how wellness is experienced.
  • Scalability: standardized clinical playbooks, membership ARPU, data feedback loops (DNA & methylation), and a franchise‑ready footprint.
  • Resilience: diversified revenue (regenerative medicine, performance, anti‑aging, recovery) and recurring membership economics.

Governance & Board

BioLife Science operates with transparent, disciplined governance — aligning clinical integrity with sustainable growth.

  • Board of Directors: leaders across regenerative medicine, healthcare operations, hospitality, and franchising.
  • Medical Advisory Council: clinicians and scientists overseeing protocol safety, efficacy, and compliance.
  • Corporate Governance: ethical standards, risk management, and investor accountability.

Expansion Roadmap

2025

Market Entry

First centers opening in Houston, Austin, and Dallas, establishing the BioLife flagship experience.

2026

Scale Corporate Clinics

Grow to 15 corporate‑owned clinics across major U.S. metros with standardized operating playbooks.

2027+

Hybrid Growth

Roll out 30 franchise territories with a target of 45+ clinic openings per year. Begin Europe/Asia entry via master franchise and JV partnerships.

Investor FAQ

What does BioLife Science do?

BioLife Science operates upscale wellness centers combining regenerative medicine, performance therapies, and concierge‑style care inside a membership model.

What differentiates BioLife?

A blend of medical oversight, DNA & methylation‑anchored personalization, and hospitality‑level environments — designed for scale via corporate units and franchising.

Where are you operating today?

Launch markets are Houston, Austin, and Dallas in 2025, followed by multi‑market U.S. expansion.

How do memberships work?

Members receive personalized plans, priority scheduling, concierge onboarding, and access to targeted protocols across recovery, performance, anti‑aging, and longevity.

How can I contact the team?

Use the contact link above to reach Investor Relations for conversations regarding strategy, partnerships, or franchise interest.

Forward‑Looking Statements

This page includes forward‑looking statements regarding BioLife Science’s growth, market opportunities, and business strategy. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that may cause actual results to differ materially. Nothing on this page constitutes an offer to sell or a solicitation to buy securities.